Clinical Trials Directory

Trials / Completed

CompletedNCT04013139

Relationship Between Cardiopulmonary Exercise Testing and Ca-P in Chronic Kidney Disease (CKD)

Evaluation of the Relationship Between Cardiopulmonary Exercise Testing (CPET ) Abnormalities and Ca-P Status in CKD Stage3-5

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Shahid Beheshti University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Reductions in exercise capacity associated with exercise intolerance augment cardiovascular disease risk and predict mortality in chronic kidney disease. This study utilized cardiopulmonary exercise testing to (a) investigate mechanisms of exercise intolerance; (b) unmask subclinical ca and p and vitamin D abnormalities that may precede cardiovascular disease in chronic kidney disease.

Detailed description

Cardiopulmonary exercise testing will carry out in Stage 3-5 chronic kidney disease patients ; estimated glomerular filtration rate \<60 ml/min/1.73 m2) and biochemistry will be added (Ca P Via D PTH FGF23).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCPETCPET

Timeline

Start date
2020-01-01
Primary completion
2021-08-01
Completion
2021-10-01
First posted
2019-07-09
Last updated
2022-01-28

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT04013139. Inclusion in this directory is not an endorsement.

Relationship Between Cardiopulmonary Exercise Testing and Ca-P in Chronic Kidney Disease (CKD) (NCT04013139) · Clinical Trials Directory